--- title: "Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/280379979.md" description: "Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News" datetime: "2026-03-24T15:00:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280379979.md) - [en](https://longbridge.com/en/news/280379979.md) - [zh-HK](https://longbridge.com/zh-HK/news/280379979.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280379979.md) | [繁體中文](https://longbridge.com/zh-HK/news/280379979.md) # Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers | ACQC Stock News ### Related Stocks - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md) - [SPAC and New Issue ETF (SPCX.US)](https://longbridge.com/en/quote/SPCX.US.md) - [Plum Acquisition Corp. III (PLMJ.US)](https://longbridge.com/en/quote/PLMJ.US.md) - [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md) - [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md) - [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md) - [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md) - [Tiga Acquisition Corp. II (TTO.US)](https://longbridge.com/en/quote/TTO.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md) - [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md) - [RF ACQUISITION CORP II COM USD0.0001 (S/R 01/05/2026) (RFAIR.US)](https://longbridge.com/en/quote/RFAIR.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md) ## Related News & Research - [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/en/news/281025352.md) - [Merck's Enlicitide Decanoate Shows Greater LDL-C Reduction Than Oral Non-Statins At 8 Weeks](https://longbridge.com/en/news/281051985.md) - [Ultragenyx clears IND for UX016 to advance Phase 1/2 GNEM study funded by patient group](https://longbridge.com/en/news/281024362.md) - [Teva Pharmaceutical Gets US FDA Approval for Prolia Biosimilar; Xoliar Biosimiliar Applications Accepted in US, Europe](https://longbridge.com/en/news/281026919.md) - [09:35 ETHengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy](https://longbridge.com/en/news/281030940.md)